Physician profile
Candice E Sumrall
NPI 1447836168
$11,212.64
in general payments reported to CMS, 2019-2025
25 companies · $3,647 in 2025
The $3,647 reported for 2025 was more than what 98% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $766 · 2022: $1,944 · 2023: $2,397 · 2024: $2,459 · 2025: $3,647.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,094 · Education: $330 · Grant: $78.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,093.81 |
| Education | $330.35 |
| Grant | $78.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $3,036.83 | 2021-2025 | Fasenra, Airsupra, Breztri |
| Glaxosmithkline, LLC. | $1,875.75 | 2021-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Genzyme Corporation | $963.32 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $744.57 | 2021-2025 | Ofev, Jascayd, Stiolto Respimat |
| Regeneron Healthcare Solutions, INC. | $704.75 | 2021-2025 | Dupixent |
| Mylan Specialty L.P. | $651.55 | 2021-2024 | Yupelri, Yupelri |
| Amgen INC. | $488.79 | 2022-2025 | Tezspire |
| Mallinckrodt Hospital Products INC. | $463.05 | 2022-2025 | Acthar |
| Insmed, INC. | $381.46 | 2022-2025 | Arikayce, Brinsupri |
| Baxter Healthcare | $281.29 | 2023-2025 | Hillrom - Life 2000 Ventilation System, Hillrom - Vest System Model 105 Home Care |
| Grifols USA, LLC | $270.18 | 2025 | Prolastin-C Liquid |
| Ani Pharmaceuticals, INC. | $243.42 | 2024-2025 | Purified Cortrophin Gel |
| Viatris Specialty LLC | $221.75 | 2025 | Yupelri |
| Verona Pharma, INC. | $197.68 | 2025 | Ohtuvayre |
| Jazz Pharmaceuticals INC. | $127.79 | 2024-2025 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $124.59 | 2023-2025 | Vest Therapy Und, (Ak6) Vest Therapy |
| Electromed, INC. | $111.54 | 2022-2025 | Smartvest |
| Sanofi-Aventis U.S. LLC | $78.99 | 2024 | |
| Merck Sharp & Dohme LLC | $62.67 | 2021-2025 | Keytruda, Zerbaxa |
| United Therapeutics Corporation | $56.33 | 2021-2025 | Tyvaso |
| Lilly USA, LLC | $39.53 | 2025 | Zepbound |
| Pfizer INC. | $26.93 | 2024 | |
| Abbvie INC. | $22.66 | 2023 | |
| Novartis Pharmaceuticals Corporation | $19.29 | 2023 | |
| Itamar Medical INC | $17.93 | 2023 | Watchpatone |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Candice Sumrall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.